SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (1248)12/22/1997 7:29:00 PM
From: Cosmo Daisey  Read Replies (1) | Respond to of 7041
 
Bill,
UFEM is a rehash of Tassaway company from the 70's that I bought at $6 and held to $42 and sold long and short and it went to .10.
The same scams keep coming back. The UV light that kills bacteria in e-coli infested material is back for about the fifth time in my investing career. The story is so compelling the artists keep using it again and again. Sorry I missed UFEM.
Can I assume by your postings that you are short ZONA?
CD



To: Bill Wexler who wrote (1248)12/23/1997 10:47:00 AM
From: Tokyo VD  Respond to of 7041
 
Bill Wexler's post included "We think the product will be successful and will produce revenues and profits much sooner than expected,'' says Michael Schonberg of Dreyfus Equity Growth Funds.

I believe Schonberg bought Macrochem, but I don't think he bought Zonagen.

Tokyo


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News